Pelvic exenteration for primary and recurrent gynaecological malignancies

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 134, Issue 2, 2007, Pages 243-248

  de Wilt, Johannes H W ^a   van Leeuwen, Diederik H J ^a   Logmans, Adriaan ^a   Verhoef, Cornelis ^a   Kirkels, Wim J ^a   Vermaas, Maarten ^a   Ansink, Anca C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Exenteration; Gynaecology; Pelvic; Surgery

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROURACIL; MITOMYCIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; MORBIDITY; OVERALL SURVIVAL; PATIENT REFERRAL; PELVIS EXENTERATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REOPERATION; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 34548846121     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.07.025     Document Type: Article

References (22)

1. Crozier M., Morris M., Levenback C., Lucas K.R., Atkinson E.N., and Wharton J.T. Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol 58 (1995) 74-78
2. Estape R., and Angioli R. Surgical management of advanced and recurrent cervical cancer. Semin Surg Oncol 16 (1999) 236-241
3. Brunschwig A. Complete excision of the pelvic viscera for advanced carcinoma. Cancer 1 (1948) 177
4. Shingleton H.M., Soong S.J., Gelder M.S., Hatch K.D., Baker V.V., and Austin Jr. J.M. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73 (1989) 1027-1034
5. Roberts W.S., Cavanagh D., Bryson S.C., Lyman G.H., and Hewitt S. Major morbidity after pelvic exenteration: a 7-year experience. Obstet Gynecol 69 (1987) 617-621
6. Sharma S., Odunsi K., Driscoll D., and Lele S. Pelvic exenterations for gynecological malignancies: 20-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer 15 (2005) 475-482
7. Roos E.J., Van Eijkeren M.A., Boon T.A., and Heintz A.P. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer. Int J Gynecol Cancer 15 (2005) 624-629
8. Miller B., Morris M., Rutledge F., et al. Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol 50 (1993) 94-99
9. Morley G.W., Hopkins M.P., Lindenauer S.M., and Roberts J.A. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 74 (1989) 934-943
10. Lopez M.J., and Spratt J.S. Exenterative pelvic surgery. J Surg Oncol 72 (1999) 102-114
11. Matthews C.M., Morris M., Burke T.W., Gershenson D.M., Wharton J.T., and Rutledge F.N. Pelvic exenteration in the elderly patient. Obstet Gynecol 79 (1992) 773-777
12. Kaplan E.S.M.P. Nonparametric estimation from incomplete obeservations. J Am Stat Assoc 53 (1958) 457-481
13. Morris M., Alvarez R.D., Kinney W.K., and Wilson T.O. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol 60 (1996) 288-291
14. Kasamatsu T., Onda T., Yamada T., and Tsunematsu R. Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma. Int J Gynaecol Obstet 89 (2005) 39-44
15. Stanhope C.R., Webb M.J., and Podratz K.C. Pelvic exenteration for recurrent cervical cancer. Clin Obstet Gynecol 33 (1990) 897-909
16. Friedlander M., and Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 7 (2002) 342-347
17. Beitler J.J., Anderson P.S., Wadler S., et al. Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?. Int J Radiat Oncol Biol Phys 38 (1997) 143-148
18. Barakat R.R., Goldman N.A., Patel D.A., Venkatraman E.S., and Curtin J.P. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol 75 (1999) 99-102
19. Houvenaeghel G., Moutardier V., Karsenty G., et al. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol 92 (2004) 680-683
20. Soper J.T., Berchuck A., Creasman W.T., and Clarke-Pearson D.L. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 35 (1989) 93-98
21. Nuyttens J.J., Kolkman-Deurloo I.K., Vermaas M., et al. High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 58 (2004) 106-112
22. Vermaas M., Ferenschild F.T.J., Nuyttens J.J., et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Rectum Colon 48 (2005) 918-928